Ken Griffin Silo Pharma, Inc. Transaction History
Citadel Advisors LLC
- $550 Billion
- Q2 2025
A detailed history of Ken Griffin (Citadel Advisors LLC) transactions in Silo Pharma, Inc. stock. As of the latest transaction made, Citadel Advisors LLC holds 28,160 shares of SILO stock, worth $19,430. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,160
Previous 20,689
36.11%
Holding current value
$19,430
Previous $24,000
29.17%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding SILO
# of Institutions
14Shares Held
407KCall Options Held
0Put Options Held
0-
Advisor Shares Investments LLC Bethesda, MD184KShares$127,1220.02% of portfolio
-
Two Sigma Securities, LLC New York, NY43.2KShares$29,8210.0% of portfolio
-
Geode Capital Management, LLC Boston, MA39.3KShares$27,1210.0% of portfolio
-
Ursa Fund Management, LLC37.5KShares$25,8740.03% of portfolio
-
Xtx Topco LTD London, X026.8KShares$18,5070.0% of portfolio
About Silo Pharma, Inc.
- Ticker SILO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 3,137,910
- Market Cap $2.17M
- Description
- Silo Pharma, Inc. operates as a developmental stage biopharmaceutical company. The company focuses on merging traditional therapeutics with psychedelic research for patients with depression, post-traumatic stress disorder, Alzheimer's, Parkinson's, and other rare neurological disorders. It has a scientific research agreement with the University ...